Daniel Ferrer Vinals

Daniel Ferrer Vinals

Auto-generated profile, based on publicly available information

Daniel Ferrer Vinals

School of Public Health, University of Alberta, Edmonton, AB T6G 2E1, Canada

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2014 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
PKPavel I. Kitov
Pavel I. Kitov
DVDaniel F. Vinals
Daniel F. Vinals
SNSimon Ng
Simon Ng
KTKatrina F. Tjhung
Katrina F. Tjhung
RDRatmir Derda
Ratmir Derda

14 September 2018 in Peptide Science
Verified
Journal Article
Closed access
PDF file
DVDaniel Ferrer Vinals
Daniel Ferrer Vinals
PKPavel I. Kitov
Pavel I. Kitov
ZTZhijay Tu
Zhijay Tu
CZChunxia Zou
Chunxia Zou
Christopher CairoChristopher Cairo
Christopher Cairo
RDRatmir Derda
Ratmir Derda

24 September 2025 in iScience
Verified
Journal Article
Open access
DVDaniel Ferrer Vinals
Daniel Ferrer Vinals
MHMohammad Rafiul Hoque
Mohammad Rafiul Hoque
OOOpeyemi Ernest Oludada
Opeyemi Ernest Oludada
EJEthan B. Jansen
Ethan B. Jansen
CMCatherine J. Mitran
Catherine J. Mitran
SYStephanie Yanow
Stephanie Yanow
Antibody responses to protein antigens are driven by epitope hierarchies that promote the immunogenicity of select epitopes. For antigenically variable pathogens, immune responses toward conserved epitopes are critical to elicit strain-transcending antibodies, yet these epitopes are often subdominant. Designing vaccines that focus immune responses to these epitopes requires an understanding of which components can overcome subdominance. Using the Plasmodium vivax Duffy binding protein with a defined subdominant region, we investigated how immunization strategies affect the immunogenicity of this region. We demonstrated that antigens with mutations in immunodominant epitopes, combined with the adjuvants GLA-SE or alum, overcame the subdominance of this region. However, these effects were largely negated by MHCII restriction. Further, robust antibody responses toward subdominant epitopes depend on boosting, which alters the epitope hierarchy and enables the recruitment of germinal center B cells specific to the subdominant epitopes. Our study provides valuable insights for designing subunit vaccines targeting subdominant epitopes.